| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0025-7125(02)00010-X |
| P698 | PubMed publication ID | 12168560 |
| P50 | author | James D. Bowen | Q87776570 |
| Walter A. Kukull | Q37386731 | ||
| P2860 | cites work | Multi-infarct dementia. | Q53309361 |
| Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. | Q53316390 | ||
| Mutations in the Tau gene cause frontotemporal dementia. | Q53532279 | ||
| NSAIDs and incident Alzheimer’s disease. the Rotterdam study | Q57782138 | ||
| Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups | Q59549757 | ||
| Prevalence and outcomes of vascular cognitive impairment | Q60712647 | ||
| Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study | Q72059302 | ||
| Association between an alpha(2) macroglobulin DNA polymorphism and late-onset Alzheimer's disease | Q73097974 | ||
| A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging | Q73434963 | ||
| Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE | Q22010705 | ||
| Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity | Q22010912 | ||
| Purification and cloning of amyloid precursor protein beta-secretase from human brain | Q22010914 | ||
| Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease | Q22248076 | ||
| Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families | Q27860677 | ||
| Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 | ||
| Mild cognitive impairment: clinical characterization and outcome | Q28140626 | ||
| Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase | Q29042710 | ||
| Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease | Q29614952 | ||
| Smoking and the occurrence of Alzheimer's disease: cross-sectional and longitudinal data in a population-based study | Q30572719 | ||
| Early diagnosis of Alzheimer dementia based on clinical and biological factors | Q31476991 | ||
| Age-related cognitive decline, mild cognitive impairment or preclinical Alzheimer's disease? | Q31566966 | ||
| Incidence of dementia and Alzheimer's disease: a reanalysis of data from Rochester, Minnesota, 1975-1984. | Q32054539 | ||
| Genetic risk factors in Alzheimer's disease | Q33588353 | ||
| Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau. | Q33590019 | ||
| Genes and susceptible loci of Alzheimer's disease | Q33609365 | ||
| Estrogen actions in the central nervous system | Q33658556 | ||
| Mitochondrial genome lesions in the pathogenesis of sporadic Alzheimer's disease | Q33719238 | ||
| Alzheimer's disease: perspectives for the new millennium | Q33764363 | ||
| A genetic dichotomy model for the inheritance of Alzheimer's disease and common age-related disorders | Q33764374 | ||
| A historical review of the concept of vascular dementia: lessons from the past for the future | Q33803105 | ||
| Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease | Q33827267 | ||
| Neuropathology of Alzheimer's disease: what is new since A. Alzheimer? | Q33827598 | ||
| Risk factors and differential diagnosis of Alzheimer's disease | Q33827611 | ||
| Alzheimer disease: protective factors | Q33841866 | ||
| Molecular genetics of Alzheimer's disease. | Q33842568 | ||
| Hachinski's ischemic score and the diagnosis of vascular dementia: a review | Q34347828 | ||
| Inverse relation between Braak stage and cerebrovascular pathology in Alzheimer predominant dementia. | Q35454178 | ||
| Estrogen use and early onset Alzheimer's disease: a population-based study | Q35454336 | ||
| Apparent mtDNA heteroplasmy in Alzheimer's disease patients and in normals due to PCR amplification of nucleus-embedded mtDNA pseudogenes | Q36833539 | ||
| Alzheimer's disease after remote head injury: an incidence study | Q36901829 | ||
| Smoking and dementia in male British doctors: prospective study | Q37326045 | ||
| Estrogen, cognition, and a woman's risk of Alzheimer's disease | Q38455260 | ||
| Risk of Alzheimer's disease and duration of NSAID use. | Q39457609 | ||
| Head trauma and risk of dementia and Alzheimer's disease: The Rotterdam Study | Q39524796 | ||
| Low education and childhood rural residence: risk for Alzheimer's disease in African Americans | Q39526829 | ||
| Early-life risk factors and the development of Alzheimer's disease | Q39528518 | ||
| Apolipoprotein E is a relevant susceptibility gene that affects the rate of expression of Alzheimer's disease | Q40496600 | ||
| APOE is a major susceptibility gene for Alzheimer's disease | Q40535799 | ||
| Smoking and Alzheimer's disease: a review of the epidemiological evidence | Q40705975 | ||
| Alzheimer's disease: genetic studies and transgenic models | Q40826156 | ||
| The role of presenilin-1 in the gamma-secretase cleavage of the amyloid precursor protein of Alzheimer's disease. | Q40906099 | ||
| Four companies announce discovery of beta-secretase gene | Q40906371 | ||
| Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies | Q41075378 | ||
| Operational criteria for senile dementia of Lewy body type (SDLT) | Q41091449 | ||
| Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: a current appraisal | Q41189090 | ||
| The gene defects responsible for familial Alzheimer's disease | Q41288332 | ||
| Effect of age, ethnicity, and head injury on the association between APOE genotypes and Alzheimer's disease | Q41307805 | ||
| The epidemiology of estrogen replacement therapy and Alzheimer's disease | Q41471946 | ||
| The effect of estrogen replacement therapy on cognitive function in women: a critical review of the literature | Q41657831 | ||
| Estrogen replacement therapy and cognitive decline in memory-impaired post-menopausal women | Q41681346 | ||
| No association between the HLA-A2 allele and Alzheimer disease. | Q41699404 | ||
| Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial | Q41718766 | ||
| Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study | Q41722422 | ||
| The EURODEM collaborative re-analysis of case-control studies of Alzheimer's disease: implications for public health | Q43671083 | ||
| Undifferentiated dementia, Alzheimer's disease and vascular dementia: age- and gender-related incidence in Liverpool. The MRC-ALPHA Study | Q43754512 | ||
| Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers | Q44026421 | ||
| Mutation screening of the tau gene in patients with early-onset Alzheimer's disease | Q44468725 | ||
| Educational attainment and socioeconomic status of patients with autopsy-confirmed Alzheimer disease | Q44811936 | ||
| The incidence of dementia: a meta-analysis | Q45174488 | ||
| Incidence and risk of dementia. The Rotterdam Study | Q45282189 | ||
| Estrogen therapy in postmenopausal women: effects on cognitive function and dementia | Q46765861 | ||
| Alpha-2 macroglobulin is genetically associated with Alzheimer disease | Q47714048 | ||
| The prognosis of mild cognitive impairment in the elderly. | Q48330824 | ||
| Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop | Q48342894 | ||
| Vascular dementia: a contemporary review of epidemiology, diagnosis, prevention, and treatment | Q48353931 | ||
| Mitochondrial DNA mutations in Alzheimer's disease | Q48567102 | ||
| Ibuprofen: effect on inducible nitric oxide synthase | Q48581095 | ||
| Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. | Q50537933 | ||
| The influence of smoking on the risk of Alzheimer's disease. | Q50644766 | ||
| Cognitive function and apolipoprotein E in very old adults: findings from the Nun Study. | Q50659622 | ||
| Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease. | Q50907793 | ||
| Head injury and risk of Alzheimer's disease by apolipoprotein E genotype. | Q50936085 | ||
| Headache in a population-based elderly cohort. An ancillary study to the Italian Longitudinal Study of Aging (ILSA). | Q50966826 | ||
| Rate of memory decline in AD is related to education and occupation: cognitive reserve? | Q51979242 | ||
| Cognitive reserve and mortality in dementia: the role of cognition, functional ability and depression. | Q51979883 | ||
| Education and incident Alzheimer's disease: a biased association due to selective attrition and use of a two-step diagnostic procedure? | Q51983216 | ||
| Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging. | Q51994955 | ||
| Sensitivity and specificity of some neuropsychological markers of Alzheimer dementia. | Q52037358 | ||
| The construct validity of the ischemic score of Hachinski for the detection of dementias. | Q52067971 | ||
| Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability. | Q52081940 | ||
| Epidemiology of dementia and Alzheimer's disease. | Q53222688 | ||
| Vascular risks and incident dementia: results from a cohort study of the very old. | Q53223154 | ||
| Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. | Q53224110 | ||
| Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease. | Q53224962 | ||
| Recent advances in the genetics of Alzheimer's disease. | Q53225915 | ||
| Alzheimer's disease in 22 twin pairs--13-year follow-up: hormonal, infectious and traumatic factors. | Q53226479 | ||
| Postmenopausal estrogen replacement therapy and risk of AD: a population-based study. | Q53227026 | ||
| Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists. | Q53232489 | ||
| A polymorphism in the tau gene associated with risk for Alzheimer's disease. | Q53232649 | ||
| Tau gene polymorphisms and apolipoprotein E epsilon4 may interact to increase risk for Alzheimer's disease. | Q53232657 | ||
| Lack of association of the alpha2-macroglobulin locus on chromosome 12 in AD. | Q53232968 | ||
| Alpha2 macroglobulin and the risk of Alzheimer's disease. | Q53232972 | ||
| Cardiovascular and other risk factors for Alzheimer's disease and vascular dementia. | Q53235124 | ||
| P433 | issue | 3 | |
| P921 | main subject | epidemiology | Q133805 |
| dementia | Q83030 | ||
| P304 | page(s) | 573-590 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | Medical Clinics of North America | Q15761972 |
| P1476 | title | Dementia epidemiology | |
| P478 | volume | 86 |
| Q40022251 | A brief computerized self-screen for dementia |
| Q33773972 | A nationwide survey of mild cognitive impairment and dementia, including very mild dementia, in Taiwan |
| Q36942274 | Age and apoE associations with complex pathologic features in Alzheimer's disease |
| Q34504328 | Androgen Deprivation Therapy and Future Alzheimer's Disease Risk |
| Q39204570 | Androgen deprivation therapy for prostate cancer and dementia risk: a systematic review and meta-analysis |
| Q35007862 | Assessment of mild dementia with amyloid and dopamine terminal positron emission tomography |
| Q46872931 | Biomarkers for Alzheimer's Disease Diagnosis. |
| Q58056371 | Do medical treatments increase the risk of substance abuse in older people with dementia |
| Q30476804 | Emotion regulation deficits in frontotemporal lobar degeneration and Alzheimer's disease |
| Q48217444 | Epicentral disruption of structural connectivity in Alzheimer's disease. |
| Q31065291 | Functional MRI in the early detection of dementias |
| Q31143202 | Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: insights from functional MRI studies |
| Q34102457 | Functional and structural MR imaging in neuropsychiatric disorders, Part 1: imaging techniques and their application in mild cognitive impairment and Alzheimer disease |
| Q37059452 | Glial cell dysregulation: a new perspective on Alzheimer disease |
| Q37221663 | Index of alpha/theta ratio of the electroencephalogram: a new marker for Alzheimer's disease |
| Q37636324 | Intracellular calcium signalling in Alzheimer's disease |
| Q33511725 | Large-scale functional brain network abnormalities in Alzheimer's disease: insights from functional neuroimaging |
| Q37227438 | Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls |
| Q34145777 | Mapping the Alzheimer's brain with connectomics |
| Q37165577 | Memantine combined with an acetyl cholinesterase inhibitor - hope for the future? |
| Q30989943 | Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease |
| Q37490689 | Neuronal networks in Alzheimer's disease |
| Q33317928 | Occupational exposure to extremely low frequency electric and magnetic fields and Alzheimer disease: a meta-analysis |
| Q22242016 | Occupational risk factors in Alzheimer's disease: a review assessing the quality of published epidemiological studies |
| Q35804300 | Personal Strengths and Health Related Quality of Life in Dementia Caregivers from Latin America |
| Q45974410 | Predicting brain network changes in Alzheimer's disease with link prediction algorithms. |
| Q24650014 | Protein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseases |
| Q90399865 | Role of Neurofilament Light Chain as a Potential Biomarker for Alzheimer's Disease: A Correlative Meta-Analysis |
| Q37421455 | Stability of clinical etiologic diagnosis in dementia and mild cognitive impairment: results from a multicenter longitudinal database |
| Q35224202 | Stem cell technology for neurodegenerative diseases. |
| Q38532565 | TMS as a Tool for Examining Cognitive Processing |
Search more.